Premium
Aquestive Therapeutics Inc (AQST)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.45 | -12.893982808 | 3.49 | 3.54 | 2.95 | 1717879 | 3.13038183 | CS |
| 4 | -0.09 | -2.87539936102 | 3.13 | 3.63 | 2.87 | 2045454 | 3.22268699 | CS |
| 12 | -2.06 | -40.3921568627 | 5.1 | 5.225 | 2.87 | 1726791 | 3.46456113 | CS |
| 26 | -1.3 | -29.9539170507 | 4.34 | 5.8 | 2.87 | 1486469 | 4.18148272 | CS |
| 52 | 0.38 | 14.2857142857 | 2.66 | 6.23 | 2.24 | 1850930 | 3.94520768 | CS |
| 156 | 0.6 | 24.5901639344 | 2.44 | 6.23 | 0.618 | 949523 | 3.10189241 | CS |
| 260 | -1.33 | -30.4347826087 | 4.37 | 9.465 | 0.618 | 871200 | 3.82980113 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
